Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03423238 · ClinicalTrials.gov registry record · NA
Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE)
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT03423238: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT03423238 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03423238, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Although coronary heart disease (CHD) treatment guidelines recognize obesity as a major modifiable risk factor,2 nearly half of all CHD patients are obese and the current standard of care fails to implement evidence-based obesity treatment for this high-risk population. Multiple lines of evidence suggest that weight loss improves outcomes in CHD patients. The primary goal of this study is to determine the feasibility of adding a 6-month behavioral weight loss intervention to exercise-based cardiac rehabilitation.
Primary Outcome
Total number of participants who met all inclusion/exclusion criteria and were enrolled in the study
Interventions
- OTHER Exercise
- BEHAVIORAL Health Education
- BEHAVIORAL Behavioral Modification
- OTHER Exercise Compliance
- DIETARY_SUPPLEMENT Calorie-Restricted Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-03-21 |
| Est. Completion | 2020-04-10 |
| Phase | NA |
What the finished NCT03423238 record still lists
NCT03423238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Exercise is the first listed.
NCT03423238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03423238 about?
NCT03423238 is a clinical study titled "Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE)". Although coronary heart disease (CHD) treatment guidelines recognize obesity as a major modifiable risk factor,2 nearly half of all CHD patients are obese and the current standard of care fails to implement evidence-based obesity treatment for this high-risk population. Multiple lines of evidence su...
What is the current status of trial NCT03423238?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2018-03-21. Estimated completion is 2020-04-10.
What interventions are being tested in trial NCT03423238?
The interventions under investigation include: Exercise (OTHER), Health Education (BEHAVIORAL), Behavioral Modification (BEHAVIORAL), Exercise Compliance (OTHER), Calorie-Restricted Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03423238?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03423238's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI